ON THE PEN
On The Pen GLP-1 News, Mike Donnelly-Boylen, Ann MetzGLP-1 and obesity medicine news.
| Platform |  | Pricing | Freemium | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 370 | Subscribers | Read | onthepen.substack.com |
Curious about how many subscribers ON THE PEN has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over three million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #194 | |
| #110 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
GLP-1 Update: CT-388 vs Tirzepatide, Wegovy Pill, Super Bowl Ads
Hey OTP community, today Dave and I hopped on our MWF LIVE and covered a few GLP-1 topics:
Tirzepatide on Notice: New GLP/GIP Data STUNS
When Roche acquired Carmot Therapeutics in late 2023, the move was widely read as strategic optionality. A way to buy exposure to obesity without signaling urgency. At the time, Carmot’s lead asset CT-388 had produced early weight loss sign...
PCOS: A Tirzepatide Trial. Finally.
Polycystic ovary syndrome has long lived in a strange clinical gray zone. It is extremely common, poorly served, and often treated as a side effect of weight rather than a disorder with its own biology. That framing has shaped everything fr...
Winter Storm: Keeping GLP-1 Meds Safe
FIND EVERYTHING WE TALK ABOUT HERE:
Authors
The writers behind this newsletter.
On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. On The Pen is a top Substack best-seller.
Mike Donnelly-Boylen is a GLP-1 access and obesity care advocate. He writes The Mission Brief to highlight advocacy opportunities and evidence-based voices, and shares lived experience and practical tips on TikTok @mike.onamission2.
Guest writer for https://onthepen.substack.com/
Frequently Asked Questions
How can I access the email archive for ON THE PEN?
You can find recent issues that have been published by ON THE PEN on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does ON THE PEN have?
To see how many people subscribe to ON THE PEN, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in ON THE PEN?
Newsletter advertising can be extremely effective when it's done right. Before you pitch ON THE PEN as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like ON THE PEN?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact ON THE PEN using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to ON THE PEN?
Scroll up to where it says Similar Newsletters to see other publications like ON THE PEN. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact ON THE PEN?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.